| miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer E Gallardo, A Navarro, N Vinolas, RM Marrades, T Diaz, B Gel, A Quera, ... Carcinogenesis 30 (11), 1903-1909, 2009 | 407 | 2009 |
| Overlapping expression of microRNAs in human embryonic colon and colorectal cancer M Monzo, A Navarro, E Bandres, R Artells, I Moreno, B Gel, R Ibeas, ... Cell research 18 (8), 823-833, 2008 | 244 | 2008 |
| Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma A Navarro, T Diaz, A Martinez, A Gaya, A Pons, B Gel, C Codony, G Ferrer, ... Blood, The Journal of the American Society of Hematology 114 (14), 2945-2951, 2009 | 209 | 2009 |
| Hematopoiesis-related microRNA expression in myelodysplastic syndromes A Pons, B Nomdedeu, A Navarro, A Gaya, B Gel, T Diaz, S Valera, ... Leukemia & lymphoma 50 (11), 1854-1859, 2009 | 119 | 2009 |
| Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients R Artells, I Moreno, T Diaz, F Martinez, B Gel, A Navarro, R Ibeas, ... European journal of cancer 46 (3), 642-649, 2010 | 99 | 2010 |
| Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis T Diaz, A Navarro, G Ferrer, B Gel, A Gaya, R Artells, B Bellosillo, ... PloS one 6 (4), e18856, 2011 | 91 | 2011 |
| Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer M Campayo, A Navarro, N Vinolas, T Diaz, R Tejero, JM Gimferrer, ... European Respiratory Journal 41 (5), 1172-1178, 2013 | 85 | 2013 |
| A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma M Campayo, A Navarro, N Vinolas, R Tejero, C Munoz, T Diaz, ... PloS one 6 (7), e22509, 2011 | 83 | 2011 |
| Prognostic implications of miR‐16 expression levels in resected non‐small‐cell lung cancer A Navarro, T Diaz, E Gallardo, N Viñolas, RM Marrades, B Gel, ... Journal of surgical oncology 103 (5), 411-415, 2011 | 81 | 2011 |
| Role of miR‐200 family members in survival of colorectal cancer patients treated with fluoropyrimidines T Diaz, R Tejero, I Moreno, G Ferrer, A Cordeiro, R Artells, A Navarro, ... Journal of surgical oncology 109 (7), 676-683, 2014 | 75 | 2014 |
| Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation CF de Larrea, A Navarro, R Tejero, N Tovar, T Díaz, MT Cibeira, L Rosinol, ... Clinical cancer research 18 (13), 3697-3704, 2012 | 71 | 2012 |
| MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia M Diaz-Beya, S Brunet, J Nomdedeu, R Tejero, T Diaz, M Pratcorona, ... Leukemia 28 (4), 804-812, 2014 | 70 | 2014 |
| Acute myeloid leukemia with translocation (8; 16)(p11; p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene M Diaz-Beya, A Navarro, G Ferrer, T Diaz, B Gel, M Camos, M Pratcorona, ... Leukemia 27 (3), 595-603, 2013 | 66 | 2013 |
| Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression C Fernandez de Larrea, I Isola, A Pereira, MT Cibeira, L Magnano, ... Leukemia 32 (6), 1427-1434, 2018 | 63 | 2018 |
| A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma A Navarro, T Díaz, N Tovar, F Pedrosa, R Tejero, MT Cibeira, L Magnano, ... Oncotarget 6 (3), 1874, 2015 | 54 | 2015 |
| The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling T Díaz, V Rodríguez, E Lozano, MP Mena, M Calderón, L Rosiñol, ... haematologica 102 (10), 1776, 2017 | 53 | 2017 |
| Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma E Lozano, MP Mena, T Díaz, B Martin-Antonio, S León, ... Clinical Cancer Research 26 (17), 4688-4698, 2020 | 37 | 2020 |
| MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients A Navarro, C Munoz, A Gaya, M Díaz-Beyá, B Gel, R Tejero, T Díaz, ... PloS one 8 (5), e64716, 2013 | 33 | 2013 |
| Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide MT Cibeira, CF de Larrea, A Navarro, T Díaz, D Fuster, N Tovar, L Rosiñol, ... Leukemia research 35 (9), 1178-1183, 2011 | 33 | 2011 |
| Impact of global and gene-specific DNA methylation pattern in relapsed multiple myeloma patients treated with bortezomib CF de Larrea, B Martín-Antonio, MT Cibeira, A Navarro, N Tovar, T Díaz, ... Leukemia research 37 (6), 641-646, 2013 | 24 | 2013 |
